| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/28/1997 | US5597805 Peritoneal dialysis solutions |
| 01/28/1997 | US5597804 N-sulfonylarginine keto-amide compounds |
| 01/28/1997 | US5597803 Bradykinin peptides with modifications at the N terminus |
| 01/28/1997 | US5597802 In combination with an osmolyte and a stabilizer in a buffered solution; enhances animal growth |
| 01/28/1997 | US5597801 Bactericides, fungicides |
| 01/28/1997 | US5597800 Treatment with lys-plasminogen of reperfusion injury and brain edema caused by ischemia |
| 01/28/1997 | US5597799 Recombinant agents affecting thrombosis |
| 01/28/1997 | US5597798 Taxol and epidermal growth factor used to enhance treatment of ovarian cancer |
| 01/28/1997 | US5597797 Administering growth hormone and insulin-like growth factor |
| 01/28/1997 | US5597796 Transdermal insulin |
| 01/28/1997 | US5597711 Factor VIII binding domain of von Willebrand factor |
| 01/28/1997 | US5597710 Genetic engineering |
| 01/28/1997 | US5597709 Human growth hormone splice variants hGHV-2(88) and hGHV-3(53) |
| 01/28/1997 | US5597707 Diagnosis and treatment of lung, breast, colon, and ovarian cancer, recognition of cell membrane protein |
| 01/28/1997 | US5597691 Enzyme inhibitors |
| 01/28/1997 | US5597607 Process for preparing fractionated soybean proteins and foods using the same |
| 01/28/1997 | US5597578 TGF-β protein compositions for inhibition of cell proliferation |
| 01/28/1997 | US5597573 Lipid-A analogs: new monosaccharide and disaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities |
| 01/28/1997 | US5597571 Eimeria antigenic composition which elicits antibodies against avian coccidiosis |
| 01/28/1997 | US5597570 Protein recognized by antibodies raised against native P28 of schistosoma mansoni |
| 01/28/1997 | US5597569 Bryodin 2 a ribosome-inactivating protein isolated from the plant Bryonia dioica |
| 01/28/1997 | US5597567 Blocking cell adhesion molecules and treating animals with ocular inflammation |
| 01/28/1997 | US5597563 Depletion of thymic antigen presenting cells |
| 01/28/1997 | US5597562 Oral dosage form of biologically active proteins |
| 01/28/1997 | US5597552 Dentinal desensitizing compositions |
| 01/28/1997 | CA2061270C Method and composition for treating reperfusion injury |
| 01/28/1997 | CA1338878C 14-beta-gal mammalian lectins |
| 01/23/1997 | WO1997002421A1 Pumping device |
| 01/23/1997 | WO1997002362A1 Nucleic acid encoding a signal mediator protein that induces cellular morphological alterations |
| 01/23/1997 | WO1997002354A1 INTERACTION OF p53 WITH TRANSCRIPTION FACTOR DP-1 |
| 01/23/1997 | WO1997002351A1 Recombinant protein having bacteriophage endosialidase enzymatic activity |
| 01/23/1997 | WO1997002348A1 Immunogenic detoxified mutant of cholera toxins |
| 01/23/1997 | WO1997002347A1 A human map kinase homolog |
| 01/23/1997 | WO1997002345A1 Tnf modulation |
| 01/23/1997 | WO1997002342A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 01/23/1997 | WO1997002291A1 Method of producing fibrin-specific antibodies using soluble fibrin polymers as an immunogen |
| 01/23/1997 | WO1997002290A1 ANTIFas LIGAND ANTIBODIES AND ASSAY METHOD BY USING THE SAME |
| 01/23/1997 | WO1997002289A1 Peptide inhibitors of fibronectine |
| 01/23/1997 | WO1997002288A1 Purification of dalbaheptide antibiotics by isoelectric focusing |
| 01/23/1997 | WO1997002287A1 Parevins and tachytegrins |
| 01/23/1997 | WO1997002286A1 Novel antibiotic peptides |
| 01/23/1997 | WO1997002285A1 Macrolides |
| 01/23/1997 | WO1997002284A1 New thrombin inhibitors, their preparation and use |
| 01/23/1997 | WO1997002280A1 Breast specific genes and proteins |
| 01/23/1997 | WO1997002048A1 Compositions for the treatment and diagnosis of body weight disorders, including obesity |
| 01/23/1997 | WO1997002045A1 Therapeutic agents and autoimmune diseases |
| 01/23/1997 | WO1997002043A1 Prevention of a disease having the characteristics of diabetes |
| 01/23/1997 | WO1997002042A1 Biologically active composition comprising cyclosporine |
| 01/23/1997 | WO1997002041A1 Transdermal and oral treatment of androgenic alopecia |
| 01/23/1997 | WO1997002016A1 Preparations and methods for the treatment of t cell mediated diseases |
| 01/23/1997 | WO1997002004A2 Methods for treating diabetes |
| 01/23/1997 | WO1997001959A1 Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits |
| 01/23/1997 | WO1997000063A3 Urocortin peptides |
| 01/23/1997 | WO1996040940A3 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 01/23/1997 | WO1996040918A3 Novel cd40l mutein |
| 01/23/1997 | WO1996040915A3 Novel ctla4/cd28 ligands and uses therefor |
| 01/23/1997 | WO1996040777A3 Synthetic peptides and pharmaceutical compositions comprising them |
| 01/23/1997 | WO1996040743A3 Inhibitors of factor xa |
| 01/23/1997 | WO1996040250A3 Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 01/23/1997 | WO1996040073A3 Composition for sustained release of non-aggregated erythropoietin |
| 01/23/1997 | WO1996040072A3 Composition for sustained release of human growth hormone |
| 01/23/1997 | WO1996038558A3 A human purinergic p2u receptor |
| 01/23/1997 | DE19628895A1 Bioactive metal RNA polypeptide |
| 01/23/1997 | DE19526752A1 Recombinant papilloma-like virus particles with deletions in L1 or L2 proteins |
| 01/23/1997 | DE19526174A1 Mittel gegen Tumorwachstum Agents against tumor growth |
| 01/23/1997 | CA2226258A1 Recombinant protein having bacteriophage endosialidase enzymatic activity |
| 01/23/1997 | CA2226219A1 Biologically active composition comprising cyclosporine |
| 01/23/1997 | CA2226121A1 Parevins and tachytegrins |
| 01/23/1997 | CA2226011A1 Compositions for the treatment and diagnosis of body weight disorders, including obesity |
| 01/23/1997 | CA2225824A1 Breast specific genes and proteins |
| 01/23/1997 | CA2225454A1 Methods for treating diabetes |
| 01/23/1997 | CA2224940A1 Interaction of p53 with transcription factor dp-1 |
| 01/23/1997 | CA2224715A1 Macrolides |
| 01/23/1997 | CA2222371A1 Nucleic acid encoding a signal mediator protein that induces cellular morphological alterations |
| 01/23/1997 | CA2198729A1 A novel human map kinase homolog |
| 01/22/1997 | EP0754753A1 Novel human tissue-type plasminogen activator variant |
| 01/22/1997 | EP0754751A1 Novel deoxyribonuclease |
| 01/22/1997 | EP0754702A2 Cyclopentane-beta-amino acid-tripeptides |
| 01/22/1997 | EP0754678A2 Improvement of physiological tolerance of pharmaceutical active beta-amino acids |
| 01/22/1997 | EP0754464A2 Methods of treating neuropeptide Y-associated conditions |
| 01/22/1997 | EP0754463A2 Stabilized aqueous liquid preparation of blood coagulation factor XIII |
| 01/22/1997 | EP0754459A1 Composition containing glycans corresponding to transferrin glycans as an active principle for the induction of immune tolerance against antigens |
| 01/22/1997 | EP0754451A1 Liposome for destroying hiv and cells infected by said virus |
| 01/22/1997 | EP0754302A1 Methods and apparatus for synthesizing labeled combinatorial chemical libraries |
| 01/22/1997 | EP0754237A1 An adenovirus supervector system |
| 01/22/1997 | EP0754234A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICE rel-II) |
| 01/22/1997 | EP0754231A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 01/22/1997 | EP0754228A1 $g(a)-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY |
| 01/22/1997 | EP0754227A1 Chimeric complement inhibitor proteins |
| 01/22/1997 | EP0754225A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 01/22/1997 | EP0754195A1 Btf2 complex proteins and uses thereof |
| 01/22/1997 | EP0754194A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/22/1997 | EP0754193A1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure |
| 01/22/1997 | EP0754192A1 Circularly permuted ligands and circularly permuted chimeric molecules |
| 01/22/1997 | EP0754189A1 Receptor modulating agents and methods relating thereto |
| 01/22/1997 | EP0754188A1 Oligonucleotides with anti-cytomegalovirus activity |
| 01/22/1997 | EP0754187A1 Growth arrest homeobox gene |
| 01/22/1997 | EP0754059A1 Methods and compositions useful for inhibition of angiogenesis |
| 01/22/1997 | EP0754058A1 Wound healing |
| 01/22/1997 | EP0754054A1 Antirestenosis protein |